Geron's Q3 Loss Narrows, Revenue Increases

MT Newswires Live11-07

Geron (GERN) reported a Q3 loss Thursday of $0.04 per diluted share, narrowing from a loss of $0.08 a year earlier.

Analysts surveyed by Capital IQ expected a loss of $0.09.

Revenue for the quarter ended Sept. 30 was $28.3 million, up from $164,000 a year earlier.

Analysts polled by Capital IQ expected $19 million.

For fiscal 2024, the company said it expects total operating expenses of about $260 million to $270 million.

The company also said its existing cash, cash equivalents and marketable securities, together with anticipated revenue from US sales of Rytelo, will be sufficient to fund its projected operating requirements for at least the next 12 months.

Price: 4.43, Change: +0.16, Percent Change: +3.63

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment